Review
Published on 06 Oct 2022
Monoclonal antibodies in cervical malignancy-related HPV
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.904790
- 6,541 views
- 13 citations
Type at least 3 characters
906 articles
Articles
Original Research
Published on 05 Oct 2022
Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1021558
- 2,501 views
- 6 citations
Review
Published on 03 Oct 2022
Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.994726
- 2,797 views
- 2 citations
Clinical Trial
Published on 30 Sep 2022
The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient’s dream study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.960387
- 4,567 views
- 11 citations
Original Research
Published on 29 Sep 2022
Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.957608
- 1,680 views
- 4 citations
Original Research
Published on 29 Sep 2022
APOBEC3B is overexpressed in cervical cancer and promotes the proliferation of cervical cancer cells through apoptosis, cell cycle, and p53 pathway
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.864889
- 4,070 views
- 9 citations
Review
Published on 29 Sep 2022
Mechanisms of mutant β-catenin in endometrial cancer progression
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1009345
- 5,096 views
- 15 citations
Original Research
Published on 28 Sep 2022
Increased diversity of a cervical microbiome associates with cervical cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1005537
- 3,619 views
- 11 citations
Original Research
Published on 27 Sep 2022
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.970918
- 7,510 views
- 7 citations
Case Report
Published on 23 Sep 2022
Human amniotic membrane for myocutaneous dehiscence after a radical surgical treatment of vulvar cancer: A case report
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1009884
- 1,701 views
Original Research
Published on 23 Sep 2022
Reclassification of endometrial cancer and identification of key genes based on neural-related genes
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.951437
- 2,624 views
- 4 citations
Case Report
Published on 23 Sep 2022
Case report: Strategies for improving outcomes in patients with primary ovarian small-cell neuroendocrine carcinoma
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.954289
- 1,664 views
- 2 citations
Original Research
Published on 23 Sep 2022
Is preoperative ultrasound tumor size a prognostic factor in endometrial carcinoma patients?
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.993629
- 1,521 views
- 4 citations
Original Research
Published on 23 Sep 2022
Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.948298
- 2,444 views
- 2 citations
Original Research
Published on 23 Sep 2022
Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.946113
- 3,059 views
- 1 citation
Original Research
Published on 21 Sep 2022
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.946319
- 2,345 views
- 11 citations